Table 5.

Signaling mechanisms are involved in the high-risk score group.

Name	Size	ES	NES	NOM P
Cell cycle	124	0.66915077	2.1871314	0
Spliceosome	126	0.64206976	2.083224	0
DNA replication	36	0.837718	2.0672143	0
Mismatch repair	23	0.80036765	2.062228	0
Pathogenic Escherichia coli infection	55	0.5739781	2.056669	0
Homologous recombination	28	0.7681676	2.0361679	0
P53 signaling pathway	68	0.49579692	1.8950231	0
Pyrimidine metabolism	97	0.5173413	1.9280515	0.001923077
Nucleotide excision repair	44	0.6324002	1.995188	0.001980198
Base excision repair	33	0.6285262	1.8693517	0.002
Proteasome	44	0.7988379	2.0141854	0.002040816
Oocyte meiosis	112	0.4684853	1.8251096	0.004140787
Pentose phosphate pathway	27	0.57422036	1.7523918	0.005825243
Glycolysis gluconeogenesis	61	0.50060135	1.7604159	0.01010101
Ubiquitin mediated proteolysis	133	0.4287824	1.6589828	0.018907564
Bladder cancer	42	0.39720345	1.5345889	0.02296451
Pancreatic cancer	70	0.41440853	1.598584	0.024948025
Small-cell lung cancer	84	0.41004965	1.5795516	0.02631579
Galactose metabolism	25	0.50981605	1.6308589	0.027985075
Renal cell carcinoma	70	0.37961188	1.518121	0.028077753
Regulation of actin cytoskeleton	212	0.37622863	1.5810093	0.028688524
Drug metabolism other enzymes	51	0.4489914	1.5682174	0.029850746
Pathways in cancer	325	0.31233284	1.4214869	0.042105265
Progesterone mediated oocyte maturation	85	0.3916816	1.5144613	0.04375

Note: ES: enrichment score; NES: normalized enrichment score; NOM: nominal.